Disparities in Lung Cancer Screening in the U.S.
Author Information
Author(s): Tseng Tung-Sung, Li Chien-Ching, Lin Hui-Yi, Witmeier Kelsey N, Chiu Yu-Wen, Celestin Michael, Trapido Edward J
Primary Institution: LSU Health Sciences Center
Hypothesis
The study investigates multi-level factors associated with low-dose computed tomography (LDCT) screening uptake among high-risk smokers in the U.S.
Conclusion
The use of LDCT screening among eligible smokers remains low, indicating a need for improved access and promotion of screening services.
Supporting Evidence
- The overall utilization rate of LDCT screening is only 18.4%.
- LDCT screening rates varied by state, ranging from 6.2% to 31.1%.
- Higher numbers of lung cancer screening facilities were associated with increased screening rates.
Takeaway
Many people who should get lung cancer screenings aren't getting them, and we need to make it easier for them to do so.
Methodology
The study used 2017-2021 BRFSS data and state-level variables to analyze factors affecting LDCT screening uptake.
Participant Demographics
Respondents from 29 states, including various socioeconomic and health backgrounds.
Statistical Information
P-Value
< 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website